Page last updated: 2024-10-20

purine and Recrudescence

purine has been researched along with Recrudescence in 5 studies

1H-purine : The 1H-tautomer of purine.
3H-purine : The 3H-tautomer of purine.
9H-purine : The 9H-tautomer of purine.
7H-purine : The 7H-tautomer of purine.

Research Excerpts

ExcerptRelevanceReference
"Frontline treatment of hairy cell leukemia (HCL) with a single course of the purine nucleoside analog (PNA) produces a high rate of complete remission (CR) with prolonged durations."8.12Treatment outcomes with purine nucleoside analog alone or with rituximab for hairy cell leukemia at first relapse. ( Brander, D; Gonter-Aubin, K; Hanlon, A; Hill, BT; Hu, R; Kabel, C; Khajavian, S; Madanat, Y; Mato, A; Mian, A; Park, JH; Pinilla-Ibarz, J; Shadman, M; Stephens, DM; Tallman, M; Wei, W, 2022)
"Frontline treatment of hairy cell leukemia (HCL) with a single course of the purine nucleoside analog (PNA) produces a high rate of complete remission (CR) with prolonged durations."4.12Treatment outcomes with purine nucleoside analog alone or with rituximab for hairy cell leukemia at first relapse. ( Brander, D; Gonter-Aubin, K; Hanlon, A; Hill, BT; Hu, R; Kabel, C; Khajavian, S; Madanat, Y; Mato, A; Mian, A; Park, JH; Pinilla-Ibarz, J; Shadman, M; Stephens, DM; Tallman, M; Wei, W, 2022)
"Although hairy cell leukemia (HCL) was identified in 1958 by Bouroncle and colleagues, HCL remains in 2015 a mysterious disease."2.52New insights in the management of patients with hairy cell leukemia. ( Cornet, E; Damaj, G; Troussard, X, 2015)
"Relapse is the leading cause of mortality in children with acute lymphoblastic leukemia (ALL)."1.42Negative feedback-defective PRPS1 mutants drive thiopurine resistance in relapsed childhood ALL. ( Bai, Y; Chen, H; Chen, J; Chen, S; Chen, Y; Ding, J; Ding, L; Du, A; Ferrando, A; Gu, L; Huang, X; Jin, L; Kang, H; Kirschner-Schwabe, R; Li, B; Li, H; Li, W; Liang, H; Lu, G; Lu, H; Ma, X; Shen, S; Tang, J; Tzoneva, G; von Stackelberg, A; Wang, S; Wu, T; Yang, JJ; Yang, M; Zhang, J; Zhou, BB, 2015)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (80.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Hu, R1
Wei, W1
Mian, A1
Gonter-Aubin, K1
Kabel, C1
Mato, A1
Stephens, DM1
Hanlon, A1
Khajavian, S1
Shadman, M1
Brander, D1
Madanat, Y1
Park, JH1
Tallman, M1
Pinilla-Ibarz, J1
Hill, BT1
Tzoneva, G2
Dieck, CL1
Oshima, K1
Ambesi-Impiombato, A1
Sánchez-Martín, M1
Madubata, CJ1
Khiabanian, H1
Yu, J1
Waanders, E1
Iacobucci, I1
Sulis, ML1
Kato, M1
Koh, K1
Paganin, M1
Basso, G1
Gastier-Foster, JM1
Loh, ML1
Kirschner-Schwabe, R2
Mullighan, CG1
Rabadan, R1
Ferrando, AA1
Topp, ZZ1
Saven, A1
Li, B1
Li, H1
Bai, Y1
Yang, JJ1
Chen, Y1
Lu, G1
Ma, X1
Wu, T1
Li, W1
Lu, H1
Ding, L1
Liang, H1
Huang, X1
Yang, M1
Jin, L1
Kang, H1
Chen, S1
Du, A1
Shen, S1
Ding, J1
Chen, H1
Chen, J1
von Stackelberg, A1
Gu, L1
Zhang, J1
Ferrando, A1
Tang, J1
Wang, S1
Zhou, BB1
Cornet, E1
Damaj, G1
Troussard, X1

Reviews

2 reviews available for purine and Recrudescence

ArticleYear
Hairy cell leukemia: a 'hair-raising' update.
    Expert review of hematology, 2014, Volume: 7, Issue:5

    Topics: Antibodies, Monoclonal; Antineoplastic Agents; Bone Marrow; Drug Therapy, Combination; Humans; Leuke

2014
New insights in the management of patients with hairy cell leukemia.
    Current opinion in oncology, 2015, Volume: 27, Issue:5

    Topics: Antibodies, Monoclonal; Antineoplastic Agents; B-Lymphocytes; Disease-Free Survival; Humans; Immunot

2015

Other Studies

3 other studies available for purine and Recrudescence

ArticleYear
Treatment outcomes with purine nucleoside analog alone or with rituximab for hairy cell leukemia at first relapse.
    European journal of haematology, 2022, Volume: 108, Issue:5

    Topics: Humans; Leukemia, Hairy Cell; Nucleosides; Purine Nucleosides; Purines; Recurrence; Rituximab; Treat

2022
Clonal evolution mechanisms in NT5C2 mutant-relapsed acute lymphoblastic leukaemia.
    Nature, 2018, 01-25, Volume: 553, Issue:7689

    Topics: 5'-Nucleotidase; Animals; Cell Proliferation; Clonal Evolution; Disease Models, Animal; Drug Resista

2018
Negative feedback-defective PRPS1 mutants drive thiopurine resistance in relapsed childhood ALL.
    Nature medicine, 2015, Volume: 21, Issue:6

    Topics: Adolescent; Child; Child, Preschool; Exome; Feedback, Physiological; Female; High-Throughput Nucleot

2015